The compagny is engaged in nano-particles high technology Research & Development activities.

DiAgam has successfully developed a completely new homogeneous immunoassay technology fully adaptable on all opened automated biochemistry analysers. The method is based on the use of stable colloidal gold suspensions as reagent.

These activities enable original Ferritin, Rhumatoid factor, Antistreptolysin O, Ultrasensitive CRP, Troponin l etc... to be made available to the market.

<< Animation >>

This schematic animation shows a process of the coloïdal gold nanotechnology developed in our R&d division.